Literature DB >> 23680143

Chromoplexy: a new category of complex rearrangements in the cancer genome.

Michael M Shen1.   

Abstract

Widespread structural alterations of cancer genomes are increasingly observed in a broad spectrum of tumors. In a recent issue of Cell, Baca and colleagues describe large chains of rearrangements that coordinately affect multiple chromosomes in prostate cancer. This phenomenon of chromoplexy may define cancer subtypes and drive punctuated tumor evolution.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23680143      PMCID： PMC3673705          DOI： 10.1016/j.ccr.2013.04.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  9 in total

1.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

2.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

3.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Authors:  Christopher E Barbieri; Sylvan C Baca; Michael S Lawrence; Francesca Demichelis; Mirjam Blattner; Jean-Philippe Theurillat; Thomas A White; Petar Stojanov; Eliezer Van Allen; Nicolas Stransky; Elizabeth Nickerson; Sung-Suk Chae; Gunther Boysen; Daniel Auclair; Robert C Onofrio; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Karen Sheikh; Terry Vuong; Candace Guiducci; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Wasay M Hussain; Alex H Ramos; Wendy Winckler; Michelle C Redman; Kristin Ardlie; Ashutosh K Tewari; Juan Miguel Mosquera; Niels Rupp; Peter J Wild; Holger Moch; Colm Morrissey; Peter S Nelson; Philip W Kantoff; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

Review 4.  Chromothripsis and cancer: causes and consequences of chromosome shattering.

Authors:  Josep V Forment; Abderrahmane Kaidi; Stephen P Jackson
Journal:  Nat Rev Cancer       Date:  2012-09-13       Impact factor: 60.716

Review 5.  Common gene rearrangements in prostate cancer.

Authors:  Mark A Rubin; Christopher A Maher; Arul M Chinnaiyan
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

Review 6.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

Review 7.  Chromothripsis: chromosomes in crisis.

Authors:  Mathew J K Jones; Prasad V Jallepalli
Journal:  Dev Cell       Date:  2012-11-13       Impact factor: 12.270

8.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

9.  Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.

Authors:  Michael C Haffner; Martin J Aryee; Antoun Toubaji; David M Esopi; Roula Albadine; Bora Gurel; William B Isaacs; G Steven Bova; Wennuan Liu; Jianfeng Xu; Alan K Meeker; George Netto; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330
  9 in total
  43 in total

1.  Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.

Authors:  Brian A Walker; Konstantinos Mavrommatis; Christopher P Wardell; T Cody Ashby; Michael Bauer; Faith E Davies; Adam Rosenthal; Hongwei Wang; Pingping Qu; Antje Hoering; Mehmet Samur; Fadi Towfic; Maria Ortiz; Erin Flynt; Zhinuan Yu; Zhihong Yang; Dan Rozelle; John Obenauer; Matthew Trotter; Daniel Auclair; Jonathan Keats; Niccolo Bolli; Mariateresa Fulciniti; Raphael Szalat; Philippe Moreau; Brian Durie; A Keith Stewart; Hartmut Goldschmidt; Marc S Raab; Hermann Einsele; Pieter Sonneveld; Jesus San Miguel; Sagar Lonial; Graham H Jackson; Kenneth C Anderson; Herve Avet-Loiseau; Nikhil Munshi; Anjan Thakurta; Gareth J Morgan
Journal:  Blood       Date:  2018-06-08       Impact factor: 22.113

Review 2.  Emerging roles of long non-coding RNAs in cancer.

Authors:  Manjima Chatterjee; Sonali Sengupta
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

3.  Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.

Authors:  Jennifer A Perry; Adam Kiezun; Peter Tonzi; Eliezer M Van Allen; Scott L Carter; Sylvan C Baca; Glenn S Cowley; Ami S Bhatt; Esther Rheinbay; Chandra Sekhar Pedamallu; Elena Helman; Amaro Taylor-Weiner; Aaron McKenna; David S DeLuca; Michael S Lawrence; Lauren Ambrogio; Carrie Sougnez; Andrey Sivachenko; Loren D Walensky; Nikhil Wagle; Jaume Mora; Carmen de Torres; Cinzia Lavarino; Simone Dos Santos Aguiar; Jose Andres Yunes; Silvia Regina Brandalise; Gabriela Elisa Mercado-Celis; Jorge Melendez-Zajgla; Rocío Cárdenas-Cardós; Liliana Velasco-Hidalgo; Charles W M Roberts; Levi A Garraway; Carlos Rodriguez-Galindo; Stacey B Gabriel; Eric S Lander; Todd R Golub; Stuart H Orkin; Gad Getz; Katherine A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

4.  RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.

Authors:  Zhixiong Wang; Yulan Cheng; John M Abraham; Rong Yan; Xi Liu; Wei Chen; Sariat Ibrahim; Gary P Schroth; Xiquan Ke; Yulong He; Stephen J Meltzer
Journal:  Cancer       Date:  2017-06-22       Impact factor: 6.860

5.  Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma.

Authors:  Heyang Cui; Yong Zhou; Fang Wang; Caixia Cheng; Weimin Zhang; Ruifang Sun; Ling Zhang; Yanghui Bi; Min Guo; Yan Zhou; Xinhui Wang; Jiaxin Ren; Ruibing Bai; Ning Ding; Chen Cheng; Longlong Wang; Xuehan Zhuang; Mingwei Gao; Yongjia Weng; Yueguang Wu; Huijuan Liu; Shuaicheng Li; Shubin Wang; Xiaolong Cheng; Yongping Cui; Zhihua Liu; Qimin Zhan
Journal:  Nat Commun       Date:  2022-10-22       Impact factor: 17.694

6.  Structural variant identification and characterization.

Authors:  Parithi Balachandran; Christine R Beck
Journal:  Chromosome Res       Date:  2020-01-06       Impact factor: 5.239

7.  Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads.

Authors:  Valentí Moncunill; Santi Gonzalez; Sílvia Beà; Lise O Andrieux; Itziar Salaverria; Cristina Royo; Laura Martinez; Montserrat Puiggròs; Maia Segura-Wang; Adrian M Stütz; Alba Navarro; Romina Royo; Josep L Gelpí; Ivo G Gut; Carlos López-Otín; Modesto Orozco; Jan O Korbel; Elias Campo; Xose S Puente; David Torrents
Journal:  Nat Biotechnol       Date:  2014-10-26       Impact factor: 54.908

8.  MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.

Authors:  Patrick McCoy; Stefano Mangiola; Geoff Macintyre; Ryan Hutchinson; Ben Tran; Bernard Pope; Peter Georgeson; Matthew K H Hong; Natalie Kurganovs; Sebastian Lunke; Michael J Clarkson; Marek Cmero; Michael Kerger; Ryan Stuchbery; Ken Chow; Izhak Haviv; Andrew Ryan; Anthony J Costello; Niall M Corcoran; Christopher M Hovens
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-06-09       Impact factor: 5.554

9.  The somatic molecular evolution of cancer: Mutation, selection, and epistasis.

Authors:  Krishna Dasari; Jason A Somarelli; Sudhir Kumar; Jeffrey P Townsend
Journal:  Prog Biophys Mol Biol       Date:  2021-08-06       Impact factor: 4.799

10.  Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.

Authors:  Dan Liao; Li Zhong; Junqiang Yin; Cuiling Zeng; Xin Wang; Xingchuan Huang; Jinna Chen; Hong Zhang; Ruhua Zhang; Xin-Yuan Guan; Xintao Shuai; Jianhua Sui; Song Gao; Wuguo Deng; Yi-Xin Zeng; Jing-Nan Shen; Jian Chen; Tiebang Kang
Journal:  Nat Cell Biol       Date:  2020-06-01       Impact factor: 28.213
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.